与新型抗高血糖药物相关的减肥的外周神经并发症:一个队列研究
1Department of Neurology, Mater Hospital, Raymond Terrace, South Brisbane, QLD, Australia. c.ogorman@uq.edu.au.
Journal of neurology
|December 19, 2025
概括
新的糖尿病药物,如GLP1R激动剂和SGLT2抑制剂,可以导致体重减轻,可能导致外围神经病变. 这项研究强调了与这些药物和减肥有关的神经疾病病例,建议谨慎使用.
科学领域:
- 神经学 神经学
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 减肥通常是患者的目标,但矛盾的是,它会导致或加重神经外围神经障碍,如神经病变和神经陷.
- 较新的抗高血糖药物,包括葡萄糖类-1受体 (GLP1R) 激动剂和-葡萄糖共运输体2 (SGLT2) 抑制剂,与控制葡萄糖的同时,与显著的体重减轻有关.
研究的目的:
- 调查使用新型抗高血糖药物 (GLP1R激动剂,SGLT2抑制剂) 与外周神经疾病的发展之间的潜在联系.
- 描述神经病变的病例,暂时与这些药物诱导的体重减轻有关.
主要方法:
- 一个回顾性队列审查的成年患者评估外周神经功能障碍在2020年和2024年之间.
- 纳入标准要求在启动GLP1R激动剂,SGLT2抑制剂或二乙酶-4抑制剂后12个月内临床和/或电诊断证实外围神经障碍.
主要成果:
- 确定了五例病例,所有病例都显示了周围神经疾病 (股骨,骨,中枢,骨神经病变和陷) 与减肥之间的时间关联.
- 确定的病例涉及使用GLP1R激动剂或SGLT2抑制剂.
结论:
- 在快速减肥或通过GLP1R激动剂或SGLT2抑制剂实现的血糖正常化后,可能会出现外围神经病变和神经陷.
- 确切的机制是未知的,但可能不是直接的药物效应;建议谨慎.
- 需要进一步的研究,以确定HbA1c的安全目标和这些药物治疗期间的体重减轻.
相关概念视频
Diabetes: Symptoms, Diagnosis, and Complications
2.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K
Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
318
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
318
Diabetes Mellitus: Type 2 and Gestational
4.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Peripheral Artery Disease IV: Nursing Management
316
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
316
Peripheral Artery Disease I: Introduction
288
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
288


